Lys254

Site Information
DAVRNQRkLLAsLVk SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 38507288
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 )
Disease tissue studied:	gastric cancer ( 3 ) , lung cancer ( 1 , 2 ) , non-small cell lung cancer ( 1 , 2 , 4 , 5 ) , non-small cell lung adenocarcinoma ( 1 ) , non-small cell large cell lung carcinoma ( 1 ) , non-small cell squamous cell lung carcinoma ( 5 )
Relevant cell line - cell type - tissue:	Calu-3 (pulmonary) ( 2 ) , HCC827 (pulmonary) ( 2 ) , lung ( 1 , 2 ) , MKN-45 (gastric) ( 3 ) , NCI-H1299 (pulmonary) ( 1 ) , NCI-H1650 (pulmonary) ( 2 ) , NCI-H1703 (squamous) ( 5 ) , NCI-H1734 (pulmonary) ( 1 ) , NCI-H1944 (pulmonary) ( 1 ) , NCI-H1975 (pulmonary) ( 2 ) , NCI-H2106 (pulmonary) ( 2 ) , NCI-H3255 (pulmonary) ( 4 ) , NCI-H358 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20216; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
2	Rikova K (2013) CST Curation Set: 20217; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
3	Rikova K (2012) CST Curation Set: 16030; Year: 2012; Biosample/Treatment: cell line, MKN45/crizotinib; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
4	Rikova K (2012) CST Curation Set: 16031; Year: 2012; Biosample/Treatment: cell line, H3255/iressa; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info
5	Rikova K (2012) CST Curation Set: 16032; Year: 2012; Biosample/Treatment: cell line, H1703/gleevec; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Curated Info